Israeli startup company, Helath.io, turns cellphone into a testing lab for kidney disease
- Published | 25 February 2019
Helathy.io, plans to utilize cellphone as testing lab for kidney diseases which will grow global home healthcare software market in upcoming periods.
Global: An Israeli digital health start-up company, Healthy.io, has developed an FDA (The U.S. Food and Drug Administration)-cleared at-home smartphone urinalysis test to help people test their kidneys for proteins, a sign of damage to the organ. Healthy.io's urinalysis test, Dip.io, uses disposable strips and cups in conjunction with a smartphone camera to read and interpret results. Patients dip a stick in a self-collected urine sample, wait for it to develop, and take a picture of it against a card using the company's app. The image is anonymiseed and put on the cloud for more detailed diagnostic tests. The test has been assessed with Geisinger Health in conjunction with the National Kidney Foundation, achieving a 71 percent adherence rate among patients with hypertension who never have been tested before. The company is targeting a few major patient categories, including pregnant women, diabetics and hypertensives most at risk for kidney disease, and women who believe they may have the symptoms of UTI (urinary tract infection). Healthy.io's products are currently available in Israel and the U.K., where it recently inked a deal with Walgreens Boots Alliance subsidiary Boots UK to introduce consumer-focused UTI testing at the company's locations. In early February, Healthy.io raised $18 million in a Series B financing round led by Aleph, an Israeli-based venture capital fund, to support growth across its existing markets and to fund the commercial launch of the product in the United States.
According to BlueWeave Consulting, Due to growing pains of the industry and the subsequent nursing shortage, home care providers are placing more emphasis on ensuring appropriate visit documentation is completed rather than ensuring the information is documented thoroughly and accurately. Specifically, agencies operating on paper processes see more physically damaged or lost documentation, increased human error, and illegibility, yielding less efficient workflows and a potentially negative impact on the quality of care. Home healthcare software have the ability to streamline tasks such as data collection and reporting, which have numerous benefits such as increase efficiency in healthcare process, provide accuracy in reports, increase compliance in terms of financial claims and regulation, improve safety and security of themselves and clients. Growing pressure to reduce healthcare costs, growing patient consumerism for quality care, shortage of nursing and staff, government support and healthcare reforms will play a major role in growth of home healthcare software industry in upcoming years. Moreover, aging population across globe will be a factor for driving home healthcare software market.
According to BlueWeave Consulting‘s upcoming report, Titled-“Global Home healthcare software market By Product (Hospice Systems, Agency Software Systems, Tele-Health Systems ,Clinical Management System), By Usage Mode(Non Clinical Homecare Systems and Clinical Homecare System), By Region, Size and Forecast 2018- 2025”- Global Home Healthcare Software market is expected with grow with a significant rate in forecast period, 2018-2025, due to growing demand to reduce healthcare cost, patient readmission and increase in the quality of care in home care settings. Moreover, the presence of government initiatives to promote clinical IT solutions, growing pressure to curtail healthcare costs and rising demand for quality care. Additionally, these solutions are cost effective, ease of use and provides error free medical information with this cutting edge technology, global home health care software market is expected to create a better business opportunities in the coming years.